Provided by Tiger Trade Technology Pte. Ltd.

Spruce Biosciences, Inc.

63.40
+4.758.10%
Pre-market: 64.030.6300+0.99%05:11 EDT
Volume:147.30K
Turnover:9.09M
Market Cap:182.21M
PE:-1.65
High:64.15
Open:58.82
Low:58.00
Close:58.65
52wk High:240.00
52wk Low:7.26
Shares:2.87M
Float Shares:2.29M
Volume Ratio:1.93
T/O Rate:6.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-38.4300
EPS(LYR):-50.8298
ROE:-105.98%
ROA:-40.03%
PB:2.18
PE(LYR):-1.25

Loading ...

Spruce Biosciences Price Target Maintained With a $200.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 10

Spruce Biosciences price target lowered to $170 from $180 at Citizens

TIPRANKS
·
Mar 10

Rpt-Spruce Biosciences FY Net Income USD -38.966 Million

THOMSON REUTERS
·
Mar 09

Spruce Biosciences Inc - to Offer and Sell Common Stock up to $75 Mln Through Jefferies - SEC Filing

THOMSON REUTERS
·
Mar 09

Spruce Biosciences Inc - May Offer and Sell Common Stock up to Maximum Program Amount Under Sales Agreement - SEC Filing

THOMSON REUTERS
·
Mar 09

Spruce Biosciences Inc - Enters Open Market Sale Agreement With Jefferies Llc on March 9, 2026 - SEC Filing

THOMSON REUTERS
·
Mar 09

BRIEF-Spruce Biosciences Reports Full Year 2025 Financial Results

Reuters
·
Mar 09

Spruce Biosciences 2025 net loss narrows, secures $50 mln funding

Reuters
·
Mar 09

Spruce Biosciences FY 2025 R&D expenses fall 58% to USD 19.52 million, net loss narrows 27% to USD 38.97 million

Reuters
·
Mar 09

Spruce Biosciences Inc - Expects Cash and Cash Equivalents to Fund Current Operating Plan Into Early 2027

THOMSON REUTERS
·
Mar 09

Spruce Biosciences Inc - Bla Submission for Ta-Ert for Treatment of Sanfilippo Syndrome Type B (Mps Iiib) on Track for Q4 2026

THOMSON REUTERS
·
Mar 09

Spruce Biosciences Inc - Net Loss $39.0 Mln for Year Ended Dec 31, 2025

THOMSON REUTERS
·
Mar 09

Press Release: Spruce Biosciences Reports Full Year 2025 Financial Results and Provides Corporate Updates

Dow Jones
·
Mar 09

Spruce Biosciences names Dale Hooks chief commercial officer

Reuters
·
Mar 09

Spruce Biosciences Appoints Dale Hooks, an Accomplished Rare Disease Commercial Leader, as Chief Commercial Officer

THOMSON REUTERS
·
Mar 09

Spruce Biosciences CEO Javier Szwarcberg to Present at Leerink Global Healthcare Conference and The Citizens Life Sciences Conference

Reuters
·
Mar 03